Never miss a story

Get subscribed to our newsletter


×
Dr. Simon Angelo (L) examines Iman Steven suffering from tuberculosis, held by her mother (R) at the hospital of Doctors Without Borders (MSF), June 15, 2016, at the Protection of Civilians (PoC) site in Malakal, South Sudan. VOA

Delegates from 114 countries have agreed to take urgent action to end tuberculosis (TB) by 2030, the WHO said.

The announcement on Friday came as the delegates gathered in Moscow for the first WHO global ministerial conference on ending tuberculosis, Xinhua news agency reported.


The delegates promised to achieve strengthen health systems and improve access to the people regarding TB prevention and care so that no one is left behind.

They also agreed to mobilize sufficient and sustainable financing through increased domestic and international investments to close gaps in implementation and research.

Resources are expected to advance research and development of new tools to diagnose, treat and prevent TB, and to build accountability through a framework to track and review progress on ending TB.

“Today marks a critical landmark in the fight to end TB,” said World Health Organisation (WHO) Director-General Tedros Adhanom Ghebreyesus.

“It signals a long overdue global commitment to stop the death and suffering caused by this ancient killer.”

Though global efforts to combat TB have saved an estimated 53 million lives since 2000 and reduced the TB mortality rate by 37 per cent, progress in many countries has stalled, global targets are off-track and persistent gaps remain in TB care and prevention, according to the WHO.

As a result, TB still kills more people than any other infectious disease. Due to its antimicrobial resistance, TB is also the leading killer of people with HIV.

Representatives at the meeting, which was attended by over 1,000 participants, also promised to minimize the risk and spread of drug resistance and do more to engage people and communities affected by or at risk of TB. (IANS)


Popular

Photo by Alexander Shatov on Unsplash

Twitter has confirmed that its algorithms amplify right-leaning political content.

By Nikhila Natarajan

In a continuing study on the effects of machine learning (ML) on public conversation, Twitter has confirmed that its algorithms amplify right-leaning political content. "In six out of seven countries - all but Germany - tweets posted by accounts from the political right receive more algorithmic amplification than the political left when studied as a group," Twitter blogged.

"Right-leaning news outlets, as defined by the independent organisations, see greater algorithmic amplification on Twitter compared to left-leaning news outlets." Since 2016, Twitter users are able to choose between viewing algorithmically ordered tweets first in their home timeline or viewing the most recent tweets in reverse chronological order.

"An algorithmic home timeline displays a stream of tweets from accounts we have chosen to follow on Twitter, as well as recommendations of other content Twitter thinks we might be interested in based on accounts we interact with frequently, tweets we engage with, and more. "As a result, what we see on our timeline is a function of how we interact with Twitter's algorithmic system, as well as how the system is designed."

The new research is based on tweets of elected officials of House of Commons members in Canada, the French National Assembly, the German Bundestag, House of Representatives in Japan, Congress of Deputies of Spain, House of Commons in the UK, and official and personal accounts of House of Representatives and Senate members in the US, as well as news outlets, from April 1 to August 15, 2020.

gold Apple iPhone 6s displaying Twitter logo Tweets about political content from elected officials, regardless of party or whether the party is in power, do see algorithmic amplification when compared to political content on the reverse chronological timeline. | Photo by Sara Kurfeß on Unsplash

Keep Reading Show less
Flickr

Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal.

Even as India celebrates reaching a milestone of 100 crore Covid vaccine doses, Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal. In a video shared on his Facebook and Twitter page, Bansal hailed Sonu Kumar as a "citizen celebrity".

Bansal said that Kumar not only helped "just co-workers and family but complete strangers too. With patience, empathy and uncanny jugaad". He added that Kumar joined him "many moons ago" and completed his open school from a parking lot.

"Education has helped this wonderful man enable others to get India back on track. Bravo! The CoWin portal on Thursday mentioned that a total of 100 crore vaccine doses has been administered so far to the eligible population under the vaccination drive in India, nine months after the nationwide inoculation programme was started to protect the people against Covid-19.

"It's a cause of significant celebration and happiness," Bansal said in the video. He said that while people just help a few around them, Kumar "bridged the digital gap" for 64 people, who were finding it difficult to register themselves online on the vaccine portal. Kumar said he doesn't feel that he has contributed much towards the 100 crore vaccine dose count. "I have been able to help only 64 people, if I was able to help more I would have been happier." (IANS/ MBI)


Keep Reading Show less
VOA

A health worker counts antiretroviral drug tablets for a patient at The AIDS Support Organization (TASO) in the capital Kampala, Uganda, July 12, 2012.

KAMPALA, UGANDA — Uganda has kickstarted a trial for the injectable HIV drugs cabotegravir and rilpivirine. Researchers and those living with HIV say the trial will likely end pill fatigue, fight stigma, improve adherence and ensure patients get the right dosage.

The two drugs have been in use as tablets. The World Health Organization last year licensed their use as injectables.

Keep reading... Show less